Evaluating long-term effectiveness of neurostimulation therapy for pain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a global, prospective observational registry that aims to gather real-world clinical outcomes of Boston Scientific's neurostimulation systems for pain management. It will assess the long-term effectiveness, economic value, and technical performance of these systems when used in routine clinical practice. Participants who respond positively to a trial of the neurostimulation therapy may receive a permanent implant, with treatment tailored to individual patient needs based on clinical discretion. The study will involve multiple centers and will adhere to established inclusion and exclusion criteria.

Why it matters

Who can join: the full rules

Key Inclusion Criteria:

* Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
* Signed a valid, IRB/EC-approved informed consent form
* 18 years of age or older

Key Exclusion Criteria:

* Contraindicated for Boston Scientific neurostimulation system
* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Where it's running

• Denver Back Pain Specialists
  Greenwood Village, Colorado, United States Recruiting
• Orlando Health Neuroscience Institute, Inc
  Clermont, Florida, United States Recruiting
• South Lake Pain Institute, Inc
  Clermont, Florida, United States Recruiting
• University of Florida Shands Hospital
  Gainesville, Florida, United States Recruiting
• Ochsner Clinic Foundation
  New Orleans, Louisiana, United States Recruiting
• Willis-Knighton River Cities Clinical Research Center
  Shreveport, Louisiana, United States Recruiting

+68 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Thanh Hoang, MS
• Email: BSNClinicalTrials@bsci.com
• Phone: 855-213-9890

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FARAFLEX Mapping and Pulsed Field Ablation for Atrial Fibrillation

  This trial tests the FARAFLEX Mapping and PFA System to see if it can safely help adults with drug-refractory paroxysmal or persistent atrial fibrillation.

  Recruiting at 13 sites Boston Scientific Corporation · Jonesboro, Arkansas and 12 other locations · NCT07575269

• Fainting Detection and Early Warning Using a Wearable Monitor

  This study tests whether signals from a wearable Holter monitor can reflect the severity of orthostatic intolerance in people with fainting disorders.

  Recruiting Boston Scientific Corporation · Rochester, Minnesota · NCT07502599

• Combined CM and STN Stimulation for Motor Epilepsy

  This pilot study tests whether pairing CM thalamus DBS with STN DBS can help adults with drug‑resistant motor epilepsy.

  Recruiting Boston Scientific Corporation · Beijing, Beijing Municipality · NCT07458217

• Transcarotid Neuroprotection System with TCAR for Carotid Artery Disease

  This registry tests how well the ENROUTE Transcarotid Neuroprotection System works in real-world patients with extracranial carotid artery disease who are treated with TCAR using Boston Scientific stents.

  Recruiting Boston Scientific Corporation · St Louis, Missouri · NCT07455747

• FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation

  This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.

  Recruiting at 3 sites Boston Scientific Corporation · Split and 3 other locations · NCT07444320

• TheraSphere Y-90 glass microsphere treatment for liver tumors in Japan

  This will test whether TheraSphere Y-90 glass microspheres are safe and helpful for Japanese adults with primary or secondary liver cancer who are not candidates for standard treatments.

  Recruiting at 5 sites Boston Scientific Corporation · Nishinomiya, Hyōgo and 4 other locations · NCT07377487

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.